SMARCA4 MUTATION

Clinical trials for SMARCA4 MUTATION explained in plain language.

Never miss a new study

Get alerted when new SMARCA4 MUTATION trials appear

Sign up with your email to follow new studies for SMARCA4 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

First patients receive experimental pill targeting Hard-to-Treat cancers

Disease control Recruiting now

This is the first-ever human study of an experimental pill called PLX-61639. It is being tested in adults with advanced cancers that have a specific genetic flaw (SMARCA4 mutation) and have stopped responding to standard treatments. The main goals are to find a safe dose and see …

Matched conditions: SMARCA4 MUTATION

Phase: PHASE1 • Sponsor: Plexium, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

SMARCA4 MUTATION

Get alerted when new SMARCA4 MUTATION trials appear

First patients receive experimental pill targeting Hard-to-Treat cancers